Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM and ZituvimetTM XR (Sitagliptin / Sitagliptin and Metformin Hydrochloride) to its template formulary.